Related Experiment Video
Updated: May 24, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Proteomic identification of chaperonin-containing tail-less complex polypeptide-1 gamma subunit as a p53-responsive
1National University Medical Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. shaochinlee@yahoo.com
Abstract:
We recently reported that functional loss of p53 altered the responses of human HCT116 colon cancer cells to apoptosis triggers. To examine the molecular basis underlying the differential responses to drug treatment in the cancer cells, we performed a proteomic analysis in order to compare the protein expressions between human colon cancer cells with and those without p53 (p53(+/+) and p53(-/-)) respectively. We identified two isoelectric variants of the chaperonin-containing tail-less complex polypeptide-1 gamma subunit (TCP-1γ) from the cells, and confirmed that the two isoelectric variants were phosphorylated at tyrosine residue(s). The p53(-/-) cells had higher protein concentration of the more acidic variant of TCP-1γ compared to their p53(+/+) counterparts. Moreover, TCP-1γ was found to be co-localized with centrosome. Our results implicate a novel cell signaling loop in HCt116 cells involving p53 and TCP1-γ phosphorylation, which may be related to regulation and action of centrosomes.
Insights
Loss of p53 in colon cancer cells alters responses to drug treatment. This study identifies a novel signaling loop involving p53, TCP-1γ phosphorylation, and centrosome regulation in HCT116 cells.
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- Functional loss of p53 impacts human HCT116 colon cancer cell responses to apoptosis.
- Understanding differential drug responses in cancer cells requires molecular investigation.
Purpose of the Study:
- To compare protein expression between p53(+/+) and p53(-/-) HCT116 colon cancer cells.
- To elucidate the molecular basis for altered drug responses in p53-deficient colon cancer.
Main Methods:
- Proteomic analysis of HCT116 colon cancer cells with and without p53.
- Identification and characterization of TCP-1γ protein variants.
- Confirmation of tyrosine phosphorylation on TCP-1γ variants.
Main Results:
- Two isoelectric variants of chaperonin-containing tail-less complex polypeptide-1 gamma subunit (TCP-1γ) were identified.
- TCP-1γ variants were phosphorylated at tyrosine residue(s).
- p53(-/-) cells exhibited higher concentrations of a more acidic TCP-1γ variant and TCP-1γ co-localized with centrosomes.
Conclusions:
- A novel cell signaling loop involving p53 and TCP-1γ phosphorylation is implicated in HCT116 cells.
- This pathway may regulate centrosome function and action in colon cancer.
- Findings contribute to understanding p53's role in colon cancer cell signaling and drug response.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

